These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. Brinkkoetter PT; Olivier P; Wu JS; Henderson S; Krofft RD; Pippin JW; Hockenbery D; Roberts JM; Shankland SJ J Clin Invest; 2009 Oct; 119(10):3089-101. PubMed ID: 19729834 [TBL] [Abstract][Full Text] [Related]
3. Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes. Taniguchi Y; Pippin JW; Hagmann H; Krofft RD; Chang AM; Zhang J; Terada Y; Brinkkoetter P; Shankland SJ Am J Physiol Renal Physiol; 2012 May; 302(9):F1161-71. PubMed ID: 22262481 [TBL] [Abstract][Full Text] [Related]
4. Cyclin I and p35 determine the subcellular distribution of Cdk5. Hagmann H; Taniguchi Y; Pippin JW; Kauerz HM; Benzing T; Shankland SJ; Brinkkoetter PT Am J Physiol Cell Physiol; 2015 Feb; 308(4):C339-47. PubMed ID: 25500740 [TBL] [Abstract][Full Text] [Related]
5. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway. Zhang Y; Li H; Hao J; Zhou Y; Liu W Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis. Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491 [TBL] [Abstract][Full Text] [Related]
7. Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation. Liu C; Zhai X; Zhao B; Wang Y; Xu Z Sci Rep; 2017 Jan; 7():40979. PubMed ID: 28112194 [TBL] [Abstract][Full Text] [Related]
8. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Brinkkoetter PT; Wu JS; Ohse T; Krofft RD; Schermer B; Benzing T; Pippin JW; Shankland SJ Kidney Int; 2010 Apr; 77(8):690-9. PubMed ID: 20130526 [TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Wang CX; Song JH; Song DK; Yong VW; Shuaib A; Hao C Cell Death Differ; 2006 Jul; 13(7):1203-12. PubMed ID: 16273078 [TBL] [Abstract][Full Text] [Related]
10. Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism. Liu W; Zhang Y; Hao J; Liu S; Liu Q; Zhao S; Shi Y; Duan H J Cell Biochem; 2012 Oct; 113(10):3186-96. PubMed ID: 22614921 [TBL] [Abstract][Full Text] [Related]
11. Cyclin dependent kinase 5 (Cdk5) mediated inhibition of the MAP kinase pathway results in CREB down regulation and apoptosis in PC12 cells. Sharma M; Hanchate NK; Tyagi RK; Sharma P Biochem Biophys Res Commun; 2007 Jun; 358(2):379-84. PubMed ID: 17498664 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain. Ramos-Miguel A; García-Sevilla JA Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847 [TBL] [Abstract][Full Text] [Related]
14. The Atypical Cyclin-Dependent Kinase 5 (Cdk5) Guards Podocytes from Apoptosis in Glomerular Disease While Being Dispensable for Podocyte Development. Mangold N; Pippin J; Unnersjoe-Jess D; Koehler S; Shankland S; Brähler S; Schermer B; Benzing T; Brinkkoetter PT; Hagmann H Cells; 2021 Sep; 10(9):. PubMed ID: 34572114 [TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons. Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759 [TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. Griffin SV; Hiromura K; Pippin J; Petermann AT; Blonski MJ; Krofft R; Takahashi S; Kulkarni AB; Shankland SJ Am J Pathol; 2004 Oct; 165(4):1175-85. PubMed ID: 15466384 [TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2. Cheung ZH; Gong K; Ip NY J Neurosci; 2008 May; 28(19):4872-7. PubMed ID: 18463240 [TBL] [Abstract][Full Text] [Related]
18. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors. Schmid G; Strosznajder JB; Wesierska-Gadek J Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520 [TBL] [Abstract][Full Text] [Related]
19. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses. Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169 [TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase 5 contributes to endoplasmic reticulum stress induced podocyte apoptosis via promoting MEKK1 phosphorylation at Ser280 in diabetic nephropathy. Zhang Y; Gao X; Chen S; Zhao M; Chen J; Liu R; Cheng S; Qi M; Wang S; Liu W Cell Signal; 2017 Feb; 31():31-40. PubMed ID: 28024901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]